John D. Andersen

Most-cited papers

1. Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients

   John D. Andersen, K. Boylan, R. Jemmerson, M. Geller +7 more

   2010Journal of Ovarian Research110 citations Open access

   Semantic Scholar

   Save

2. Identification of Candidate Biomarkers in Ovarian Cancer Serum by Depletion of Highly Abundant Proteins and Differential In Gel Electrophoresis

   John D. Andersen, K. Boylan, Fei-Fei S. Xue, Lorraine B. Anderson +4 more

   2010Electrophoresis59 citations Open access

   Semantic Scholar

   Save

3. ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand

   Starchild Weivoda, John D. Andersen, Aunica Skogen, P. Schlievert +5 more

   2008JIM - Journal of Immunological Methods58 citations Open access

   Semantic Scholar

   Save

4. S100A1 Expression in Ovarian and Endometrial Endometrioid Carcinomas Is a Prognostic Indicator of Relapse-Free Survival

   M. DeRycke, John D. Andersen, K. Harrington, S. Pambuccian +4 more

   2009American Journal of Clinical Pathology56 citations Open access

   Semantic Scholar

   Save

5. Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation

   K. Boylan, Benjamin S. Misemer, M. DeRycke, John D. Andersen +5 more

   2011International Journal of Molecular Sciences42 citations Open access

   Semantic Scholar

   Save

6. Quantitative proteomic analysis by iTRAQ® for the identification of candidate biomarkers in ovarian cancer serum

   K. Boylan, John D. Andersen, Lorraine B. Anderson, LeeAnn Higgins +1 more

   2010Proteome Science18 citations Open access

   Semantic Scholar

   Save

7. Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in‐gel electrophoresis

   John D. Andersen, K. Boylan, Fei-Fei S. Xue, Lorraine B. Anderson +4 more

   201011 citations

   Semantic Scholar

   Save

8. A Cell Line–based Immunohistochemical p53 Expression Pattern Control Panel

   Imran Hussain, R. S. Howard, V. Syed, M. Allgäuer +3 more

   2019International Journal of Gynecological Pathology1 citations

   Semantic Scholar

   Save

9. Abstract GMM-016: CEREBELLIN-2 (CBLN2) IS DIFFERENTIALLY EXPRESSED IN OVARIAN CANCER SUBTYPES

   John D. Andersen, Najerie S. McMillian, W. Andersen, S. Kimbro

   20190 citations

   Semantic Scholar

   Save

10. Abstract DPOC-003: DIFFERENTIAL PROTEIN EXPRESSION ANALYSIS OF SV40–IMMORTALIZED OVARIAN SURFACE, SV40–IMMORTALIZED FALLOPIAN TUBE AND OVARIAN CANCER SUBTYPE CELL LINE SECRETOMES BY ITRAQ®

    Yaling Zhou, Daniel I. Brooks, Sumana M. Dey, LeeAnn Higgins +6 more

    20170 citations

    Semantic Scholar

    Save

11. Abstract DPOC-002: A NOVEL CELL LINE BASED IMMUNOHISTOCHEMICAL TP53 EXPRESSION PATTERN CONTROL PANEL

    V. Syed, Imran Hussain, Jeptha Johnson, P. Malafronte +4 more

    20170 citations

    Semantic Scholar

    Save

12. Abstract 4644: A cell-line based TP53 expression pattern control panel with interobserver variability and next-generation sequencing analysis

    Yaling Zhou, Sorana Raiciulescu, V. Syed, P. Malafronte +7 more

    20170 citations

    Semantic Scholar

    Save

13. Researchproteomic analysis by iTRAQ ® for the identification of candidate biomarkers in ovarian cancer serum

    K. Boylan, John D. Andersen, Lorraine B. Anderson, LeeAnn Higgins +1 more

    20100 citations

    Semantic Scholar

    Save